Surgery News and Research

RSS

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Genomic Health, Inc. today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued its final local coverage determination (LCD) approving coverage of the Oncotype DX prostate cancer test for qualified Medicare patients throughout the United States.

17 Aug 2015

Omeros plans to file patent infringement lawsuit against Par

Omeros Corporation today, in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, LLC in response to the Abbreviated New Drug Application (ANDA) filed by Par seeking FDA approval to market a generic version of Omeros' commercial drug Omidria (phenylephrine and ketorolac injection) 1%/0.3%.

17 Aug 2015

ORBERA Managed Weight Loss System receives final approval from FDA

The ORBERA Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.

14 Aug 2015

MGH papers reveal the way anesthetics affect brains of older patients and children

Recent Massachusetts General Hospital (MGH) investigations into the neurobiology underlying the effects of general anesthesia have begun to reveal the ways different anesthetic agents alter specific aspects of the brain's electrical signals, reflected by EEG (electroencephalogram) signatures. While those studies have provided information that may lead to improved techniques for monitoring the consciousness of patients receiving general anesthesia, until now they have been conducted in relatively young adult patients.

14 Aug 2015

Arterial shunt in hybrid palliation better for hypoplastic left heart syndrome treatment

Children born with the major congenital heart defect hypoplastic left heart syndrome (HLHS) often must undergo a series of corrective surgeries beginning at birth. While most have the standard three-stage Norwood procedure, a hybrid strategy has been introduced to offset some disadvantages associated with the Norwood surgeries. In a report in The Journal of Thoracic and Cardiovascular Surgery, investigators compare whether outcomes can be improved if an arterial shunt is used as a source of pulmonary blood flow rather than the more conventional venous shunt as part of the hybrid strategy of HLHS surgical reconstruction.

14 Aug 2015

Rice and UTHealth scientists awarded $1.02 million NSF grant to examine how the brain processes language

The National Science Foundation has awarded a $1.02 million grant to scientists at Rice University and the University of Texas Health Science Center at Houston Medical School to study how the brain processes language. The joint research may one day help people who lose the ability to communicate.

14 Aug 2015

Listening to music improves postoperative recovery in adult patients undergoing surgical procedure

Listening to music before, during, or after a surgical procedure is beneficial to patients and can significantly reduce pain and anxiety, and decrease the need for pain medication, according to the most comprehensive review of the evidence so far, involving almost 7000 patients, published in The Lancet.

14 Aug 2015

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.

14 Aug 2015

Rush researchers explore new stem cell therapy to treat spinal cord injuries

Researchers at Rush University Medical Center are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury. Rush is only the second center in the country currently studying this new approach.

14 Aug 2015

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published today in Cancer Research.

13 Aug 2015

FGF protein may play key role in breast and prostate cancer, shows research

Simply put, cancer is caused by mutations to genes within a cell that lead to abnormal cell growth. Finding out what causes that genetic mutation has been the holy grail of medical science for decades.

13 Aug 2015

Molecular on-off switch controls how mouse brain responds to vision loss

KU Leuven biologists have discovered a molecular on-off switch that controls how a mouse brain responds to vision loss.

13 Aug 2015

Abortions performed with Mifepristone result in shorter waiting time, earlier abortions

Nearly all abortions in Norway today are performed with the abortion pill Mifepristone. This has resulted in shorter waiting time, earlier abortions, and the possibility to have abortions at home.

13 Aug 2015

Common marker can help identify patients at high risk for deadly cardiac events

A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study led by investigators at Brigham and Women's Hospital.

13 Aug 2015

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

12 Aug 2015

New Frost & Sullivan analysis finds that wearable devices to play large role in healthcare industry

The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.

12 Aug 2015

Delaying surgery until clinical triggers emerge leads to increased mortality in patients with mitral regurgitation

Patients with mitral regurgitation face a dilemma of whether to undergo corrective surgery early, when they might have no or few symptoms, or wait until their condition worsens. Current guidelines allow for watchful waiting until certain symptoms appear that would then "trigger" the decision to proceed with surgery.

12 Aug 2015

Ion channel blockers prove useful in cancer therapy

Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of metastatic brain cancer.

12 Aug 2015

Gastric bypass surgery enhances energy expenditure

Gastric bypass surgery often leads to a sustained weight loss. Researchers at Sahlgrenska Academy have found part of the explanation: the operation enhances energy expenditure such that eating actually helps the person lose weight.

12 Aug 2015

Scientists identify molecular pathway that can contribute to vision loss in macular degeneration

Scientists have identified a pathway that leads to the formation of atypical blood vessels that can cause blindness in people with age-related macular degeneration.

12 Aug 2015

Surgery News and Research

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Omeros plans to file patent infringement lawsuit against Par

ORBERA Managed Weight Loss System receives final approval from FDA

MGH papers reveal the way anesthetics affect brains of older patients and children

Arterial shunt in hybrid palliation better for hypoplastic left heart syndrome treatment

Rice and UTHealth scientists awarded $1.02 million NSF grant to examine how the brain processes language

Listening to music improves postoperative recovery in adult patients undergoing surgical procedure

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Rush researchers explore new stem cell therapy to treat spinal cord injuries

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

FGF protein may play key role in breast and prostate cancer, shows research

Molecular on-off switch controls how mouse brain responds to vision loss

Abortions performed with Mifepristone result in shorter waiting time, earlier abortions

Common marker can help identify patients at high risk for deadly cardiac events

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

New Frost & Sullivan analysis finds that wearable devices to play large role in healthcare industry

Delaying surgery until clinical triggers emerge leads to increased mortality in patients with mitral regurgitation

Ion channel blockers prove useful in cancer therapy

Gastric bypass surgery enhances energy expenditure

Scientists identify molecular pathway that can contribute to vision loss in macular degeneration

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News